The One-Size-Fits-All Problem
Current peptide dosing is based on averages from clinical trials — typically 70kg male subjects. But your genetics determine how you actually metabolize, respond to, and benefit from peptides.
Same peptide, same dose, different results. Genetics explain why some people thrive on low doses while others need 3x the amount — and why side effects vary so dramatically.
What Science Already Knows
CYP Enzymes
CYP2D6, CYP3A4, and other cytochrome enzymes affect how quickly peptides are metabolized. Slow metabolizers need lower doses; fast metabolizers may need more.
APOE Gene
ApoE4 carriers have higher Alzheimer's risk and may respond differently to cognitive peptides. Affects BPC-157, Selank, and nootropic protocols.
GH/IGF-1 Genetics
Variations in the GHR gene affect how well GH secretagogues work. Some people are "non-responders" due to genetic variants.
GLP-1 Receptor
Variants in the GLP-1 receptor gene (GLP1R) affect how well GLP-1 agonists work for weight loss. Explains the 15-25% non-responder rate.
Genes That Matter for Peptide Therapy
Metabolism & Dosing
- CYP2D6 — Metabolizes many peptides; variants determine metabolizer status
- CYP3A4 — Key enzyme for peptide metabolism; some variants require dose adjustment
- COMT — Affects neurotransmitter modulation; relevant for cognitive peptides
Response & Efficacy
- GLP1R — GLP-1 agonist response variants
- GHR — Growth hormone receptor sensitivity
- IGF1 — IGF-1 production and sensitivity
Risk & Safety
- APOE — Alzheimer's risk, cognitive peptide response
- F5, F2 — Blood clotting variants; affects certain peptides
- BRCA1/2 — Cancer risk genes; some peptides may interact
How Genetic Testing Helps
1. Optimal Dosing
Know whether you're a slow, normal, or fast metabolizer. Adjust peptide doses accordingly from the start.
2. Predict Response
Know if you'll likely respond to a peptide before trying it. Avoid wasted time and money on unlikely responders.
3. Reduce Side Effects
Know your risk profile. Adjust protocol to minimize adverse effects based on your genetics.
4. Personalized Stacks
Build stacks based on your genetic profile rather than generic protocols.
The Future: Precision Peptide Therapy
Within the next 5-10 years, peptide protocols will be prescribed based on genetic profiles:
- Pre-prescription genetic panels — Standard before starting any peptide
- Algorithmic dosing — Algorithms incorporating genetics, labs, biometrics
- Continuous monitoring — Wearable integration with genetic baseline
- Personalized formulations — Compounding based on individual genetics